Article
Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns.
International journal of antimicrobial agents - 1 Jan 2011
Strenger Volker, Gschliesser Tanja, Grisold Andrea, Zarfel Gernot, Feierl Gebhard, Masoud Lilian, Hoenigl Martin, Resch Bernhard, Müller Wilhelm, Urlesberger Berndt
Abstract excerpt
Colonisation and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) is an emerging problem. The aim of this study was to investigate whether colistin, which is reported to be effective against multiresistant enterobacteria, prevents ESBL-E colonisation in neonates....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.